sellWeak
John C Duffy sold $15k of OLPX
General Counsel at OLAPLEX HOLDINGS, INC.. 11,730 shares at an average of $1.24, traded Apr 16, 2025, filed Apr 17, 2025.
Warning score
15Value
$15k
11,730 shares
Holdings after
668,026
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$15k at market
- 0Share of holdings soldSold 1.7% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001868726-25-000041, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 16, 2025 | SOpen-market sale Common Stock | -11,730 | $1.24 | $15k | 668,026 | Apr 17, 2025 |
Related signals
Other insiders at OLAPLEX HOLDINGS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | OLPXsell OLAPLEX HOLDINGS, INC. | Trisha L Fox Chief People Officer | $20k 16,840 shares | -2% | |
| 23Weak | OLPXbuy OLAPLEX HOLDINGS, INC. | Kenneth F Egan See Remarks. | $13k 10,000 shares | - | |
| 30Weak | OLAPLEX HOLDINGS, INC. | John C Duffy General Counsel | $50k 35,013 shares | -9% | |
| 29Weak | OLAPLEX HOLDINGS, INC. | Trisha L Fox Chief People Officer | $38k 26,526 shares | -5% | |
| 52Moderate | OLPXsell OLAPLEX HOLDINGS, INC. | Amanda Baldwin Chief Executive Officer | $803k 382,555 shares | -12% | |
| 40Moderate | OLAPLEX HOLDINGS, INC. | John P Bilbrey director | $135k 76,825 shares | +32% | |
| 41Moderate | OLAPLEX HOLDINGS, INC. | Amanda Baldwin Chief Executive Officer | $74k 43,000 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.